These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 35196794)

  • 1. Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population.
    Asamoah-Boaheng M; Goldfarb DM; Barakauskas V; Kirkham TL; Demers PA; Karim ME; Lavoie PM; Marquez AC; Jassem AN; Jenneson S; MacDonald C; Grunau B
    Microbiol Spectr; 2022 Feb; 10(1):e0145421. PubMed ID: 35196794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals.
    Hayer J; Urlaub E
    Microbiol Spectr; 2022 Jun; 10(3):e0270921. PubMed ID: 35575594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
    Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
    Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between SARS-CoV-2 Symptoms, Ct Values, and Serological Response in Vaccinated and Unvaccinated Healthcare Personnel.
    Farnsworth CW; O'Neil CA; Dalton C; McDonald D; Vogt L; Hock K; Arter O; Wallace MA; Muenks C; Amor M; Alvarado K; Peacock K; Jolani K; Fraser VJ; Burnham CD; Babcock HM; Budge PJ; Kwon JH
    J Appl Lab Med; 2023 Sep; 8(5):871-886. PubMed ID: 37478837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors.
    Grebe E; Stone M; Spencer BR; Akinseye A; Wright D; Di Germanio C; Bruhn R; Zurita KG; Contestable P; Green V; Lanteri MC; Saa P; Biggerstaff BJ; Coughlin MM; Kleinman S; Custer B; Jones JM; Busch MP
    Emerg Infect Dis; 2024 Aug; 30(8):1621-1630. PubMed ID: 38981189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Elecsys® Anti-SARS-CoV-2 and Elecsys® Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.
    Quee FA; Hogema BM; Molier M; Slot E; van den Hurk K; Zaaijer HL
    PLoS One; 2024; 19(7):e0305613. PubMed ID: 39024252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic.
    Grunau B; O'Brien SF; Kirkham TL; Helmer J; Demers PA; Asamoah-Boaheng M; Drews SJ; Karim ME; Srigley JA; Sediqi S; O'Neill D; Drennan IR; Goldfarb DM
    Ann Emerg Med; 2022 Jul; 80(1):38-45. PubMed ID: 35461719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
    Bonhomme ME; Bonhomme CJ; Strelow L; Chaudhari A; Howlett A; Breidenbach C; Hester J; Hammond C; Fuzy M; Harvey L; Swanner V; Ellis J; Greway RR; Pisciella VA; Green T; Kierstead L
    PLoS One; 2022; 17(2):e0262922. PubMed ID: 35130298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response.
    Nikiforuk AM; McMillan B; Bartlett SR; Márquez AC; Pidduck T; Kustra J; Goldfarb DM; Barakauskas V; Sinclair G; Patrick DM; Sadarangani M; Ogilvie GS; Krajden M; Morshed M; Sekirov I; Jassem AN
    Microbiol Spectr; 2022 Apr; 10(2):e0140521. PubMed ID: 35266818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19.
    Chamkhi S; Dhaouadi T; Sfar I; Mokni S; Jebri A; Mansouri D; Ghedira S; Ben Jemia E; Ben Boujemaa S; Houissa M; Aouina H; Ben Abdallah T; Gorgi Y
    Int J Immunopathol Pharmacol; 2022; 36():20587384211073232. PubMed ID: 35113728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of anti-nucleocapsid antibody assays for the detection of SARS-CoV-2 Omicron vaccine breakthroughs after various intervals since the infection.
    Springer DN; Reuberger E; Borsodi C; Puchhammer-Stöckl E; Weseslindtner L
    J Med Virol; 2023 Nov; 95(11):e29229. PubMed ID: 37966995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.
    Corchado-Garcia J; Zemmour D; Hughes T; Bandi H; Cristea-Platon T; Lenehan P; Pawlowski C; Bade S; O'Horo JC; Gores GJ; Williams AW; Badley AD; Halamka J; Virk A; Swift MD; Wagner T; Soundararajan V
    JAMA Netw Open; 2021 Nov; 4(11):e2132540. PubMed ID: 34726743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Natural SARS-CoV-2 Infection in Seroprevalence Studies Among Vaccinated Populations.
    Demmer RT; Baumgartner B; Wiggen TD; Ulrich AK; Strickland AJ; Naumchik BM; Bohn B; Walsh S; Smith S; Kline S; Stovitz SD; Yendell S; Beebe TJ; Hedberg C
    Mayo Clin Proc; 2022 Apr; 97(4):754-760. PubMed ID: 35379422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance characteristics of five SARS-CoV-2 serological assays: Clinical utility in health-care workers.
    Heffernan E; Kennedy L; Hannan MM; Ramlaul N; Denieffe S; Courtney G; Watt A; Hurley J; Lynch M; Fitzgibbon M
    Ann Clin Biochem; 2021 Sep; 58(5):496-504. PubMed ID: 33845592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals.
    Poopalasingam N; Korenkov M; Ashurov A; Strobel J; Fish I; Hellmich M; Gruell H; Lehmann C; Heger E; Klein F
    J Clin Virol; 2022 Mar; 148():105119. PubMed ID: 35248992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
    Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
    Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.